Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP764139.RAdwVhwC1eMt_h6kO4zkDk2h1oXPKi-MGWXgeWZ9daWZw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP764139.RAdwVhwC1eMt_h6kO4zkDk2h1oXPKi-MGWXgeWZ9daWZw130_assertion type Assertion NP764139.RAdwVhwC1eMt_h6kO4zkDk2h1oXPKi-MGWXgeWZ9daWZw130_head.
- NP764139.RAdwVhwC1eMt_h6kO4zkDk2h1oXPKi-MGWXgeWZ9daWZw130_assertion description "[Using a number of approaches: mouse embryonic fibroblasts (MEF) from wild-type (WT), beta-arrestins knockouts (KO), beta-arrestins 1 and 2 double KO, and MEFs with reconstituted WT beta-arrestins in the double KO cells, RNA interference (siRNA) specific knockdown of beta-arrestins, and overexpression of WT beta-arrestins, it was demonstrated that beta-arrestin 2 positively regulates LPS-induced ERK 1/2 activation and both beta-arrestins 1 and 2 negatively regulate LPS-induced NFkappaB activation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP764139.RAdwVhwC1eMt_h6kO4zkDk2h1oXPKi-MGWXgeWZ9daWZw130_provenance.
- NP764139.RAdwVhwC1eMt_h6kO4zkDk2h1oXPKi-MGWXgeWZ9daWZw130_assertion evidence source_evidence_literature NP764139.RAdwVhwC1eMt_h6kO4zkDk2h1oXPKi-MGWXgeWZ9daWZw130_provenance.
- NP764139.RAdwVhwC1eMt_h6kO4zkDk2h1oXPKi-MGWXgeWZ9daWZw130_assertion SIO_000772 17418896 NP764139.RAdwVhwC1eMt_h6kO4zkDk2h1oXPKi-MGWXgeWZ9daWZw130_provenance.
- NP764139.RAdwVhwC1eMt_h6kO4zkDk2h1oXPKi-MGWXgeWZ9daWZw130_assertion wasDerivedFrom befree-20140225 NP764139.RAdwVhwC1eMt_h6kO4zkDk2h1oXPKi-MGWXgeWZ9daWZw130_provenance.
- NP764139.RAdwVhwC1eMt_h6kO4zkDk2h1oXPKi-MGWXgeWZ9daWZw130_assertion wasGeneratedBy ECO_0000203 NP764139.RAdwVhwC1eMt_h6kO4zkDk2h1oXPKi-MGWXgeWZ9daWZw130_provenance.